ASCEND BY NTHRYS
Research Abroad Products

Epigenomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 49–60 of 200 project topics
Chromatin Accessibility Database Integration and Knowledge Mining Tool
A commercial analytics platform that aggregates and cross-references chromatin accessibility data from public repositories with proprietary research datasets to enable meta-analysis and knowledge discovery. Revenue models include B2B SaaS subscriptions for pharma R&D teams, licensing agreements with academic consortia, and premium data curation services.
Chromatin Accessibility Analytics Service Platforms Click to view more details →
Custom Chromatin Accessibility Analysis Pipeline Development and Deployment Service
A professional services offering that designs, builds, and deploys tailored bioinformatics pipelines for chromatin accessibility analysis optimized to client-specific research or clinical requirements. This service-oriented business model generates high-margin revenue through custom project fees, long-term pipeline maintenance contracts, and training programs for client bioinformatics teams.
Chromatin Accessibility Analytics Service Platforms Click to view more details →
Cell-Free DNA Methylation Profiling SaaS Platform
A cloud-based diagnostic platform that analyzes methylation patterns in circulating cell-free DNA to detect cancer, cardiovascular, and neurodegenerative diseases from blood samples. Enables clinical laboratories and hospitals to offer non-invasive early detection services with recurring subscription revenue and per-test licensing fees.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Liquid Biopsy Histone Modification Detection Commercial Kit
A ready-to-deploy diagnostic kit that measures histone post-translational modifications in plasma and serum to identify disease biomarkers and treatment response. Generates consistent consumables revenue stream through hospital procurement and clinical laboratory adoption with high test throughput capacity.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Circulating Tumor DNA Epigenetic Mutation Analysis Tool
An AI-powered bioinformatics platform that interprets epigenetic alterations in ctDNA to support oncology treatment selection and minimal residual disease monitoring. Delivers revenue through diagnostic test fees, software licensing to genomic labs, and partnership agreements with pharmaceutical companies.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Non-Invasive Prenatal Testing Epigenomic Risk Assessment Service
A managed diagnostic service using cell-free fetal DNA epigenetic markers to assess pregnancy complications and fetal development abnormalities from maternal blood. Captures high-margin revenue from obstetric clinics, fertility centers, and insurance reimbursement for expanded prenatal screening.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Multi-Disease Liquid Biopsy Epigenetic Biomarker Panel
A comprehensive commercial testing platform simultaneously detecting epigenetic signatures for cancer, diabetes, autoimmune, and cardiovascular conditions from a single blood draw. Enables clinical laboratories to monetize high-volume patient screening with premium pricing and corporate wellness program contracts.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Real-Time Epigenomic Data Processing Cloud Infrastructure
A scalable cloud-based computational platform that processes liquid biopsy epigenomic sequencing data with machine learning for rapid clinical reporting. Generates recurring software-as-a-service fees, data storage charges, and API licensing to diagnostic labs and research institutions.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Organ-Specific Injury Detection Epigenetic Liquid Biopsy System
A specialized diagnostic platform leveraging tissue-specific epigenetic signatures in circulating DNA to detect organ damage in liver, kidney, heart, and lung tissues. Addresses critical gaps in emergency medicine and intensive care monitoring with proprietary biomarkers and institutional licensing opportunities.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Pharmacogenomic Response Prediction Epigenomic Testing Service
A precision medicine platform that predicts drug efficacy and adverse reactions by analyzing epigenetic modifications in patient circulating DNA samples. Generates high-value revenue through pharmaceutical partnerships, precision oncology centers, and personalized medicine program integration.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Aging Biomarker Epigenetic Clock Liquid Biopsy Platform
A consumer and clinical-grade product that measures biological age and longevity risk through epigenetic clock analysis of cell-free DNA from blood samples. Monetizes through direct-to-consumer wellness subscriptions, anti-aging clinics, life insurance partnerships, and corporate health programs.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →
Immune Cell Infiltration Epigenetic Profiling Commercial Assay
A diagnostic assay measuring epigenetic markers of immune cell activation and tumor microenvironment composition in liquid biopsy samples for immuno-oncology applications. Drives revenue through immuno-therapy clinical trial support, checkpoint inhibitor response prediction, and collaboration licensing with biopharmaceutical companies.
Liquid Biopsy Epigenomics Diagnostic Platforms Click to view more details →